The Medical Device Coordination Group (MDCG) published several updated Device Specific Vigilance Guidance (DSVG) documents on January 30.
The EC proposed extending the transitional provisions for certain IVD devices, following adoption of Regulation (EU) 2023/607, announced January 23.
The EC proposal to delay the compliance of IVDs also proposes a gradual roll-out of the European database on medical devices, EUDAMED. The EC proposes that certain modules of EUDAMED would become mandatory before completing all six modules.
We briefly share again the requirements for Regulation 2023/607 amending the European Medical Devices Regulation (2017/745, MDR). Manufacturers must have an application with a notified body designated for the MDR for the legacy (or substitute) devices by May 26, 2024, a quality management system and an agreement with said notified body by September 26, 2024.
Manufacturers of legacy medical devices sold in the EU market will receive a regulatory reprieve when Regulation 2023/607 System and Procedure Packs goes into effect May 26, as long as certain conditions are met.
The UK’s MHRA updated its medical device legislation, which has greatly increased the UK’s current capacity to certify medical devices.
IVD manufacturers doing business in Europe will want to review regulators’ current list of priorities to maintain market access.
In this on-demand webinar, our Emergo by UL subject matter expert outlines the latest insights about Regulation EU 2023/607.
The European Commission recently published two tables on its website to help manufacturers understand national language requirements under the MDR and IVDR.
The EC has rolled out a new data dashboard to provide more transparency in medical device availability across European Union member states.